Evidence map›Paper›PMID 40800311›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2024

Test-retest performance of [

Cristina Lois, Jessie Fanglu Fu, Andrew N Salvatore, Arun H Garimella, Derek Huell, Hasan Sari, David Izquierdo Garcia, Nathaniel D Mercaldo, Bradford Dickerson, Keith A Johnson and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Evaluation of [Acta neuropathologica communications · 2026
    Article
  3. Evaluation of [Research square · 2026
    Article
  4. Quantitative Measurement of Tau Burden in a Dual-Time-Window Dynamic PET Imaging Protocol with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cristina LoisDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
Jessie Fanglu FuDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
Andrew N SalvatoreAthinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States.
Arun H GarimellaAthinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States.
Derek HuellAthinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States.
Hasan SariDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
David Izquierdo GarciaDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
Nathaniel D MercaldoDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
Bradford DickersonDepartment of Neurology, Massachusetts General Hospital, Boston, MA, United States.
Keith A JohnsonDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
Ciprian CatanaDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.
Julie C PriceDepartment of Radiology, Massachusetts General Hospital, Boston, MA, United States.

Funding

Translation of tau-selective PET radiopharmaceuticals in Alzheimers patientsR01AG052414 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI PRICE, JULIE C, VASDEV, NEIL · 2018 to 2021
$2.7M
In vivo characterization of the PET pharmacokinetic properties of T807 in humansR01AG050436 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PRICE, JULIE C · 2015 to 2017
$1.6M
Development and validation of efficient cognitive composite scores of digital tools for the detection of early pathophysiological changes in Alzheimers diseaseK99AG081457 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI FU, FANG LU (JESSIE) · 2023 to 2024
$254k
NIA NIH HHS K99 AG081457NIA NIH HHS R01 AG050436NIA NIH HHS R01 AG052414
6 · The paper itself

Abstract

Accurate interpretation of quantitative positron emission tomography (PET)outcomes hinges on understanding the test-retest variability (T-RT).Previous studies of the tau-PET ligand [

Indexed as

[ 18 F]MK-6240 test–retestAlzheimer’s diseaseextracerebral signal.positron emission tomographyquantificationtau imaging

Identifiers

PMID40800311
PMCPMC12315748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.